Rodríguez-Moranta F - Search Results

1

The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemic.

Rodríguez-Alonso L, Rodríguez-Moranta F, Maisterra S, Botargues JM, Berrozpe A, Ruíz-Cerulla A, Suris G, Camps B, Gornals JB, Guardiola J. Rodríguez-Alonso L, et al. Gastroenterol Hepatol. 2022 Jan;45(1):9-17. doi: 10.1016/j.gastrohep.2020.11.020. Epub 2021 Feb 2. Gastroenterol Hepatol. 2022. PMID: 33545240 Free PMC article. English, Spanish.

2

[Current status of treatment of inflammatory bowel disease].

Rodríguez-Moranta F, Soriano-Izquierdo A, Guardiola J. Rodríguez-Moranta F, et al. Cir Esp. 2007 Nov;82(5):254-9. doi: 10.1016/s0009-739x(07)71722-0. Cir Esp. 2007. PMID: 18021623 Free article. Review. Spanish.

3

Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.

Rodríguez-Moranta F, Trapero-Bertran M, Castells A, Mas-Canal X, Balaguer F, Pellisé M, Gonzalo V, Ocaña T, Trilla A, Piqué JM. Rodríguez-Moranta F, et al. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):405-12. doi: 10.1157/13125585. Gastroenterol Hepatol. 2008. PMID: 18783684

4

Colorectal cancer screening: strategies to select populations with moderate risk for disease.

Navarro M, Binefa G, Blanco I, Guardiola J, Rodríguez-Moranta F, Peris M; Catalan Colorectal Cancer Screening Pilot Programme Group. Navarro M, et al. Rev Esp Enferm Dig. 2009 Dec;101(12):855-60. doi: 10.4321/s1130-01082009001200005. Rev Esp Enferm Dig. 2009. PMID: 20082546 Free article.

5

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G. Azuara D, et al. Clin Colorectal Cancer. 2010 Jul;9(3):168-76. doi: 10.3816/CCC.2010.n.023. Clin Colorectal Cancer. 2010. PMID: 20643622

6

[Diagnostic performance of colonoscopy in lower gastrointestinal bleeding].

Rodriguez Moranta F, Berrozpe A, Guardiola J. Rodriguez Moranta F, et al. Gastroenterol Hepatol. 2011 Oct;34(8):551-7. doi: 10.1016/j.gastrohep.2011.06.003. Epub 2011 Aug 31. Gastroenterol Hepatol. 2011. PMID: 21885162 Review. Spanish.

7

Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.

Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D, Galter S, Esteller M, Moreno V, Capellá G. Azuara D, et al. Inflamm Bowel Dis. 2013 Jan;19(1):165-73. doi: 10.1002/ibd.22994. Inflamm Bowel Dis. 2013. PMID: 22532293

8

[Fecal calprotectin in the diagnosis of inflammatory bowel diseases].

Rodríguez-Moranta F, Lobatón T, Rodríguez-Alonso L, Guardiola J. Rodríguez-Moranta F, et al. Gastroenterol Hepatol. 2013 Jun-Jul;36(6):400-6. doi: 10.1016/j.gastrohep.2012.10.008. Epub 2013 Feb 19. Gastroenterol Hepatol. 2013. PMID: 23434080 Spanish.

9

A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.

Lobatón T, Rodríguez-Moranta F, Lopez A, Sánchez E, Rodríguez-Alonso L, Guardiola J. Lobatón T, et al. Inflamm Bowel Dis. 2013 Apr;19(5):1034-42. doi: 10.1097/MIB.0b013e3182802b6e. Inflamm Bowel Dis. 2013. PMID: 23470502

10

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V. Carmona FJ, et al. Cancer Prev Res (Phila). 2013 Jul;6(7):656-65. doi: 10.1158/1940-6207.CAPR-12-0501. Epub 2013 May 21. Cancer Prev Res (Phila). 2013. PMID: 23694962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page